Aspen Dental and Forward Science Join Forces to Enhance Periodontal Care
In a significant move set to redefine periodontal care across the United States, Aspen Dental® has announced a strategic partnership with Forward Science, a pioneering medical technology firm. This collaboration aims to make advanced periodontal treatment options, specifically the innovative PerioStōm®, readily accessible to patients at over 1,100 independently-owned Aspen Dental practices nationwide.
Tackling Gum Disease with Innovation
According to the Centers for Disease Control and Prevention (CDC), an alarming two out of five adults in the U.S. suffer from some form of periodontal disease. This condition, also known colloquially as gum disease, can lead to severe dental issues if not addressed, including inflammation and infection that jeopardize the supporting tissues around teeth. Historically, treatment often involved antibiotics, which some patients may find intolerable.
With the introduction of PerioStōm, Aspen Dental is revolutionizing recovery after routine periodontal procedures, such as scaling and root planing. Utilizing a proprietary formulation of chitosan microspheres, a biocompatible polymer, this non-drug treatment promotes healing while mitigating the potential side effects associated with traditional drug therapies.
Rute Ramalho, DDS, MS, MBA, Vice President of Hygiene Strategy Operations at The Aspen Group, stated, “Aspen Dental offices are committed to advancing innovations that improve the lives of the patients they serve. PerioStōm represents exactly the kind of innovation that aligns with our mission—enhancing clinical capabilities while elevating the patient experience through improved treatment outcomes.”
A Commitment to Improving Lives
The integration of PerioStōm into the Aspen Dental network is a significant step forward towards accessible healthcare for all. Robert J. Whitman, CEO of Forward Science, emphasized the mission to transform established technologies into effective, cost-efficient solutions designed to improve patient outcomes. “Our partnership with Aspen Dental underscores the important role PerioStōm plays in enhancing patient outcomes nationwide. Together, we have the opportunity to make a greater impact than ever before,” he remarked.
Forward Science has made a name for itself in medical technology since its founding in 2012, offering innovative solutions that empower clinicians and bolster oral health. With PerioStōm as its flagship product, the company has sought to support better patient outcomes through advanced, FDA-cleared treatments that avoid antibiotic-based approaches.
Enhancing Patient Experience
Traditional methods for managing post-procedure recovery can often involve prolonged use of medications, which may present risks or discomfort for certain patients. However, the chitosan microsphere formulation used in PerioStōm stands out for its compatibility with a broad spectrum of patients, eliminating the need for antibiotic-based therapeutics that may otherwise deter some from seeking necessary treatment.
Aspen Dental continues to uphold its mission—founded in 1998—to eliminate the obstacles patients face when seeking dental care. With over 25 years in operation, this partnership with Forward Science marks an exciting chapter in its commitment to elevating patient experiences and promoting better health outcomes for the community.
Aspen Dental remains dedicated to breaking down barriers that hinder access to quality care. The PerioStōm treatment is a testament to this mission and a harbinger of future innovations within the dental care landscape.
To learn more about the PerioStōm treatment and to schedule an appointment, visit
aspendental.com.